/PRNewswire/ Biosion, Inc. ("Biosion"), a global R&D biotechnology company, today announced the appointment of Rakesh Dixit, Ph.D., DABT to its Advisory.
- Philippe Vandeput appointed as Chief Business Officer and Rakesh Dixit joins the company's Scientific Advisory Board (SAB) - atbtherapeutics today announced the appointments of Philippe Vandeput
Pyxis Oncology Hosting Key Opinion Webinar on Antibody-Drug Conjugates Webinar on Tuesday, April 27th @ 1pmET
April 19, 2021 09:03 ET | Source: Pyxis Oncology Pyxis Oncology Cambridge, Massachusetts, UNITED STATES
CAMBRIDGE, Mass., April 19, 2021 (GLOBE NEWSWIRE) Pyxis Oncology ( Pyxis or the Company ) today announced that it will host a key opinion leader (KOL) webinar on antibody-drug conjugates on Tuesday, April 27, 2021 at 1pm Eastern Time.
The webinar will feature presentations by KOLs Jeremy Barton, M.D. and Rakesh Dixit, Ph.D., DABT, who will discuss antibody-drug conjugates (ADCs) and their potential for improving the lives of patients with difficult-to-treat cancers.
Also featured will be a presentation by Pyxis Oncology Chief Executive Officer Lara Sullivan, M.D., and Ronald Herbst, Ph.D., Chief Scientific Officer, who will discuss the Company s ADC programs.